Results 171 to 180 of about 92,350 (272)
Objective To characterize the clinical features, treatment, and outcomes of a large, international cohort of childhood‐onset Takayasu arteritis (cTAK). Methods Patients with a diagnosis of cTAK were identified in A Registry of Childhood Vasculitis and divided into subcohorts by era‐of diagnosis: pre‐biologic (PB; 1986–2006), early biologic (EB; 2007 ...
James Bistolarides +29 more
wiley +1 more source
Objective To develop, externally validate, and simplify a machine learning model to predict remission between 6 and 24 months in patients with rheumatoid arthritis (RA) initiating tumor necrosis factor inhibitors, JAK inhibitors, interleukin‐6 inhibitors, abatacept, or rituximab using data from 11 international registries in the JAK‐pot collaboration ...
Zubeyir Salis +22 more
wiley +1 more source
Investigating the Short-Term Changes of the Electrocardiogram Indicators During Hospitalization in Patients With COVID-19 Following the Use of Tocilizumab. [PDF]
Zahedi M, Houshmand G, Hosseini T.
europepmc +1 more source
Expert Perspectives: Defining and Managing Progressive Pulmonary Fibrosis in Systemic Sclerosis
Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is one of the leading causes of morbidity and mortality in SSc, affecting up to three‐quarters of patients. The disease course is highly heterogeneous, ranging from indolent, nonprogressive forms to rapidly progressive pulmonary fibrosis (PPF).
Devis Benfaremo +7 more
wiley +1 more source
ABSTRACT Drug‐induced thrombocytopenia is a condition where certain medications can significantly reduce the platelets in the blood. This can increase the risk of bleeding and bruising. We reported a case of a 73‐year‐old woman with multiple comorbidities who was admitted to the hospital with COVID‐19.
Abdullah F. Alharthi +6 more
wiley +1 more source
Lumps, Bumps, and Diagnostic Stumps: A Case Report of IgG4‐Related Disease
ABSTRACT IgG4‐related disease and idiopathic multicentric Castleman disease are rare conditions that can present with overlapping features, complicating diagnosis and delaying proper treatment.
Michael Miller +4 more
wiley +1 more source
Diagnostic Challenge of Multivessel Takayasu Arteritis—A Case Report
ABSTRACT Progressive limb claudication, pulse deficits, marked inter‐arm blood pressure differences, and elevated inflammatory markers should prompt evaluation for Takayasu arteritis. Early vascular ultrasound followed by CTA or MRA enables timely diagnosis and treatment in settings with delayed access to specialist services, reducing the risk of ...
Khaleda Parvin +6 more
wiley +1 more source
Comparative associations of Anakinra and Tocilizumab initiation with in-hospital mortality in severe COVID-19: A single-center sequential cohort study. [PDF]
Avsar FN, Kılıcaslan N, Sahutoglu T.
europepmc +1 more source
Chimeric antigen receptor T‐cell therapy as a cure for large B‐cell lymphoma
Abstract Large B‐cell lymphoma (LBCL) is cured in most patients with first‐line chemoimmunotherapy; however, 30%–40% of patients will have relapsed or refractory (R/R) disease. Of these patients, those with refractory or early relapsed LBCL may receive chimeric antigen receptor (CAR) T‐cell therapy as their second‐line treatment if they are eligible ...
Danielle S. Wallace +3 more
wiley +1 more source
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy targeting B‐cell maturation antigen (BCMA) is a highly effective treatment option for patients with relapsed refractory multiple myeloma (RRMM). However, reliable biomarkers predicting long‐term treatment response remain elusive. Germline single‐nucleotide polymorphisms (SNPs) in immune checkpoint
Elisa Suter +7 more
wiley +1 more source

